Literature DB >> 23869577

Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients.

Ching-Wei D Tzeng1, Steven A Curley, Jean-Nicolas Vauthey, Thomas A Aloia.   

Abstract

OBJECTIVES: Hepatectomy patients are known to be at significant risk for venous thromboembolism (VTE), but previous studies have not differentiated pre- versus post-discharge events. This study was designed to evaluate the timing, rate and predictors of pre- ('early') versus post-discharge ('late') VTE.
METHODS: All patients undergoing elective hepatectomy during 2005-2010 and recorded in the American College of Surgeons National Surgical Quality Improvement Program participant use file were identified. Perioperative factors associated with 30-day rates of early and late VTE were analysed.
RESULTS: A total of 7621 patients underwent 4553 (59.7%) partial, 802 (10.5%) left, 1494 (19.6%) right and 772 (10.1%) extended hepatectomies. Event rates were 1.9% for deep venous thrombosis, 1.2% for pulmonary embolus and 2.8% for VTE. Of instances of VTE, 28.6% occurred post-discharge. The median time of presentation of late VTE was postoperative day 14. Multivariate analysis determined that early VTE was associated with age ≥75 years [odds ratio (OR) 1.92, P = 0.007], male gender (OR 1.87, P = 0.002), intraoperative transfusion (OR 2.49, P < 0.001), operative time of >240 min (OR 2.28, P < 0.001), organ space infection (OSI) (OR 2.60, P < 0.001), and return to operating room (ROR) (OR 3.25, P < 0.001). Late VTE was associated with operative time of >240 min (OR 2.35, P = 0.008), OSI (OR 3.78, P < 0.001) and ROR (OR 2.84, P = 0.011).
CONCLUSIONS: Late VTE events occur in patients with clearly identifiable intraoperative and postoperative risk factors. This provides a rationale for the selective use of post-discharge VTE chemoprophylaxis in high-risk patients.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23869577      PMCID: PMC3791116          DOI: 10.1111/hpb.12130

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  23 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.

Authors:  P Mismetti; S Laporte; J Y Darmon; A Buchmüller; H Decousus
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

3.  A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

Authors:  Giancarlo Agnelli; Giorgio Bolis; Lorenzo Capussotti; Roberto Mario Scarpa; Francesco Tonelli; Erminio Bonizzoni; Marco Moia; Fabio Parazzini; Romina Rossi; Francesco Sonaglia; Bettina Valarani; Carlo Bianchini; Gualberto Gussoni
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 4.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

5.  Postoperative morbidity index: a quantitative measure of severity of postoperative complications.

Authors:  Steven M Strasberg; Bruce L Hall
Journal:  J Am Coll Surg       Date:  2011-08-25       Impact factor: 6.113

Review 6.  A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality.

Authors:  Michael J Leonardi; Marcia L McGory; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2006-11-10       Impact factor: 5.344

Review 7.  International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  D Farge; P Debourdeau; M Beckers; C Baglin; R M Bauersachs; B Brenner; D Brilhante; A Falanga; G T Gerotzafias; N Haim; A K Kakkar; A A Khorana; R Lecumberri; M Mandala; M Marty; M Monreal; S A Mousa; S Noble; I Pabinger; P Prandoni; M H Prins; M H Qari; M B Streiff; K Syrigos; H Bounameaux; H R Büller
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database.

Authors:  Thomas A Aloia; Bridget N Fahy; Craig P Fischer; Stephen L Jones; Andrea Duchini; Joseph Galati; A Osama Gaber; R Mark Ghobrial; Barbara L Bass
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

10.  Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections.

Authors:  Giuseppe Zimmitti; Robert E Roses; Andreas Andreou; Junichi Shindoh; Steven A Curley; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2012-09-07       Impact factor: 3.452

View more
  6 in total

1.  Do All Abdominal Neuroendocrine Tumors Require Extended Postoperative VTE Prophylaxis? A NSQIP Analysis.

Authors:  Nicholas J Skertich; Justin Gerard; Jennifer Poirier; Martin Hertl; Sam G Pappas; Erik Schadde; Xavier M Keutgen
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

2.  Venous Thromboembolism Prophylaxis in Liver Surgery.

Authors:  Thomas A Aloia; William H Geerts; Bryan M Clary; Ryan W Day; Alan W Hemming; Luiz Carneiro D'Albuquerque; Charles M Vollmer; Jean-Nicolas Vauthey; Giles J Toogood
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

3.  Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Authors:  B J Kim; R W Day; C H Davis; N Narula; M H Kroll; C W D Tzeng; T A Aloia
Journal:  J Thromb Haemost       Date:  2017-09-27       Impact factor: 5.824

4.  What Is "Enhanced Recovery," and How Can I Do It?

Authors:  Bradford J Kim; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2017-10-24       Impact factor: 3.452

5.  Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons.

Authors:  Matthew J Weiss; Yuhree Kim; Aslam Ejaz; Gaya Spolverato; Elliott R Haut; Kenzo Hirose; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2014-05-28       Impact factor: 3.647

6.  Development and validation of a risk calculator for post-discharge venous thromboembolism following hepatectomy for malignancy.

Authors:  Cary Jo R Schlick; Ryan J Ellis; Ryan P Merkow; Anthony D Yang; David J Bentrem
Journal:  HPB (Oxford)       Date:  2020-09-26       Impact factor: 3.647

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.